INTRODUCTION {#sec1-1}
============

Herbal products and dietary supplements are now widely available and considered as complementary approaches for health promotion. They are intensively used to treat and prevent many diseases, such as neurodegenerative disorders, dementia, aging, cancer and cardiovascular disorders.\[[@ref1][@ref2]\] Many people believe in health benefits from these herbal preparations which are often linked with their antioxidant properties. Various substances, isolated from plants, were identified as active molecules in modern medicines and many plant extracts work as complex mixtures with synergistic effects.

Aquilaria is a genus of fifteen species of a tree in the Thymelaeaceae, which is native to Southeast Asia. They occur particularly in the rain forests of Thailand, Indonesia, Cambodia, Malaysia, Vietnam, Laos, Northern India, the Philippines and Borneo. The products of Aquilaria, including agarwood, leaves, etc., have been widely used in the treatment of various kinds of pain, cough and anaphylaxis for hundreds of years in Asia.\[[@ref3][@ref4]\] In general, many Aquilaria species, such as *Aquilaria sinensis* (Lour.) Gilg., *Aquilaria agallocha* Roxb. and *Aquilaria crassna*, are considered of similar medicinal use. Pharmacological studies showed that *A. agallocha* inhibited histamine release from mast cells and suppressed the immediate hypersensitivity reaction.\[[@ref5]\] It may be potentially an anti-inflammatory and/or analgesic agent.\[[@ref6][@ref7]\] The leaves of *A. sinensis* were previously reported to have analgesic and anti-inflammatory activities.\[[@ref8]\] Leaves of *A. sinensis* also contained eight α-glucosidase inhibitors,\[[@ref9]\] which might be used as traditional medicine for the treatment of diabetes. Interestingly, many chemical ingredients with a similar structure have been isolated from both *A. sinensis* and *A. agallocha*.\[[@ref10]--[@ref12]\]

In Thailand, the leaves of *A. crassna* have been used traditionally for the treatments of various disorders and most recently they have been used as a healthy tea food additive. Although the effect of *A. crassna* on the lipopolysaccharide (LPS)-induced tumor necrosis factor-alpha (TNF-α) production by human polymorphonuclear cells (hPBMC) and cell signaling response has been shown recently,\[[@ref13]\] no other scientific study has been done to elucidate the pharmacological properties of the active ingredients of *A. crassna* in order to prove the claims.

MATERIALS AND METHODS {#sec1-2}
=====================

Plant material and extraction {#sec2-1}
-----------------------------

Dried *A. crassna* leaves (the plant\'s voucher No. NAT001-002, Faculty of Pharmaceutical Sciences, Khon Kaen University) were powdered and macerated with methanol for 24 h. The filtrate was dried using a rotary vacuum evaporator giving the desired extract in 7.95% yield based on the dried leaves. The *A. crassna* leaves extract (ACE) was dissolved fresh in water, everytime before use.

Animals {#sec2-2}
-------

Male ICR mice weighing 25-35 g, and male Sprague Dawley rats weighing 200-300 g were received from the Animal\'s House, Khon Kaen University, Khon Kaen, Thailand. They were maintained under standard environmental conditions and were fed with a standard pellet diet and water ad libitum.

Antipyretic activity {#sec2-3}
--------------------

### Baker′s yeast-induced fever {#sec3-1}

Antipyretic activity tests were performed as described.\[[@ref14]\] Rats were divided into five groups of six rats, and they were trained to remain quiet in a restraint cage. The rectal temperature (T~R~) was recorded with 0.1°C precision by inserting a lubricated digital thermometer (external diameter 3 mm) into the rectum of each animal. After measuring basal T~R~, fever was induced by a subcutaneous injection of a pyrogenic dose of Baker\'s yeast (135 mg/kg), and subsequently T~R~ was recorded every hour. Two hours after injection of yeast, either water (as the control), ACE (200, 400 or 800 mg/kg) or 150 mg/kg aspirin was administered orally to each rat, and the T~R~was recorded every hour for another 4 hours. Results are expressed as the changes of the T~R~from basal T~R~. From our study, the effect of ACE was clearly seen at 800 mg/kg. Therefore, the 800 mg/kg dose was used to study analgesic and anti-inflammatory activities.

Analgesic activity {#sec2-4}
------------------

### Hot plate test {#sec3-2}

Mice, six in each group, were tested for the reaction time by placing them on a hot plate that was thermostatically maintained at 50°C with a four-wall plexiglass container, confining the animals on the hot plate.\[[@ref14]\] Time that each mouse spent on the hot plate (until it licked or jumped in response to pain) was recorded as the reaction time. The cut-off time of the test was set at 30 seconds in order to prevent tissue damage. The reaction time of each animal was recorded as the basal reaction time. After being orally fed with either water, ACE (800 mg/kg) or aspirin (150 mg/kg), the reaction time of each animal was determined at 30, 60 and 90 min after treatment.

Anti-inflammatory activity {#sec2-5}
--------------------------

### Carrageenan-induced paw edema in rats {#sec3-3}

Rats were divided into three experimental groups ( *n* = 6). Different groups were orally treated with water (as the control), ACE (800 mg/kg) or aspirin (300 mg/kg). One hour after treatment, acute inflammation was produced by the sub plantar injection with 0.1 ml of 1% carrageenan in the right paw of the rats.\[[@ref14]\] Rat\'s paw volume was measured at 0, 1, 2 and 3 hours after carrageenan injection using a plethysmometer. The results were expressed as the changes of paw volume from the basal value.

Anti-oxidative activity {#sec2-6}
-----------------------

### DPPH antioxidant assay {#sec3-4}

Anti-oxidative activity of ACE was determined by DPPH (1,1-diphenyl-2-picrylhydrazyl) antioxidant assay as described earlier.\[[@ref15]\] In brief, the extract was dissolved in methanol into various concentrations, including 500, 250, 125, 63, 31, 16, and 8 g/ml. Ascorbic acid in methanol at 5, 2.5, 1.25, 0.63, 0.31, 0.16, and 0.08 g/ml were used as reference standard. After adding 0.1 mm DPPH, the mixture was incubated in the dark for 30 min and the absorbance was measured at 490 nm. Concentration and % inhibition of the oxidation reaction of ascorbic acid and ACE was plotted and the 50% inhibition concentrations were determined as IC~50~.

Effects of repeated doses of ACE, initial toxicity {#sec2-7}
--------------------------------------------------

Water (as the control) or ACE at the doses of 800 mg/kg or 8,000 mg/kg (10 times higher than the effective dose) was administered orally to mice, once daily for seven days. There were 10 mice in each group. Animal behavioral changes were observed immediately after treatment up to 6 hours. Body weight of each animal and numbers of dead animals (if any) were recorded daily. At the end of the experiment, certain organs (heart, kidney, liver and stomach) were isolated, weighed and observed for any gross abnormality changes.

Statistical analysis {#sec2-8}
--------------------

Results were expressed as the mean ± S.E.M. Data were assessed by one-way analysis of variance (ANOVA) and all pairwise multiple comparison procedures (Fisher LSD method). *P* value of \<0.05 was considered as statistically significant.

RESULTS {#sec1-3}
=======

Antipyretic activity {#sec2-9}
--------------------

The results of the antipyretic activity (Baker\'s yeast-induced fever) are outlined in [Figure 1](#F1){ref-type="fig"}. Animals that received Baker\'s yeast (135 mg/kg) had a significant increase in the rectal temperature 3 hours after the yeast injection, and the increase in T~R~ was continued until the end of the experiment. The animals treated with 200 mg/kg ACE showed no antipyretic effect and the animal\'s T~R~ during the observation period was comparable to the control. Animals treated with either 150 mg/kg aspirin or 400 or 800 mg/kg ACE showed a significant reduction of T~R~ at 5 and 6 hours after the yeast injection when compared to the control at the same time point.

![Effects of ACE (200, 400 or 800 mg/kg) or 150 mg/kg aspirin on rectal temperature of rats. \* and \# denoted *P*\<0.05 when compared to the control at the same time point and basal T~R~, respectively](JAIM-3-175-g001){#F1}

Hot plate reaction time in mice {#sec2-10}
-------------------------------

The results showed that aspirin 150 mg/kg and ACE 800 mg/kg could significantly increase the thermal threshold when compared to the control \[[Figure 2](#F2){ref-type="fig"}\]. The analgesic effect of 150 mg/kg aspirin could be seen at 30, 60 and 90 min after oral administration. The effect of 800 mg/kg ACE was clearly seen at 60 and 90 min after oral administration of the test extract. The magnitude of the effect of 800 mg/kg ACE was significantly less than 150 mg/kg aspirin at 60 min and identical at 90 min.

![Analgesic effect of ACE. Mice were fed with water (control), 800 mg/kg ACE or 150 mg/kg aspirin. \* and \# denoted *P*\<0.05 when compared to the control and aspirin-treated group at the same time point, respectively](JAIM-3-175-g002){#F2}

Anti-inflammatory studies {#sec2-11}
-------------------------

Following carrageenan injection, the paw edema formation was gradually increased within the 1^st^ hour for the control group, and the maximum effect was reached over the period of 3 hours \[[Figure 3](#F3){ref-type="fig"}\]. Animals treated with 300 mg/kg aspirin showed fewer swollen paws, and the paw volumes were significantly less than the control group after 2 and 3 hours. No anti-inflammatory effect of 800 mg/kg ACE could be observed.

![Carrageenan-induced paw edema test. Rats were fed with water (control), 800 mg/kg ACE or 300 mg/kg aspirin. \* *P*\<0.05 when compared to the control at the same time point](JAIM-3-175-g003){#F3}

Anti-oxidative activity {#sec2-12}
-----------------------

### DPPH antioxidant assay {#sec3-5}

As shown in [Figure 4](#F4){ref-type="fig"}, ascorbic acid, 0.08-5 g/ml, inhibited DPPH oxidation by approximately 30-80%. From 8 to 500 g/ml ACE, the inhibition was determined in the range from 36% to 91%. The anti-oxidative activities of ascorbic acid and ACE were found to have IC~50~ equal to 2.19 g/ml and 47.18 g/ml, respectively.

![Comparison of DPPH radical scavenging capacity (%) of ascorbic acid and ACE](JAIM-3-175-g004){#F4}

Effects of repeated doses of ACE {#sec2-13}
--------------------------------

In general, animals treated with ACE at either 800 or 8,000 mg/kg showed no abnormal behavior. Interestingly, the repeated oral administration of 8,000 mg/kg ACE once daily for seven days, showed a significant reduction of the animal\'s body weight from day 2 until the end of the experiment when compared to the control \[[Figure 5](#F5){ref-type="fig"}\]. No effect could be observed on weights or gross appearances of the heart, liver, kidney and stomach in animals treated with ACE at either 800 or 8,000 mg/kg for seven days (data not shown).

![ACE treatment and animal′s body weight. Mice were fed once daily with water (control) or ACE. \**P*\<0.05 when compared to the control at the same time point](JAIM-3-175-g005){#F5}

DISCUSSION {#sec1-4}
==========

In this study, it was clearly shown that the methanolic extract of *A. crassna* leaves (ACE) possesses antipyretic (Baker\'s yeast-induced fever in rats), analgesic (hot plate test in mice) and anti-oxidative (DPPH antioxidant assay) activities without anti-inflammatory activity (carrageenan-induced paw edema in rat). No effects on general behaviors of mice could be observed after repeated dose\'s treatment (seven consecutive days) of ACE, at either 800 mg/kg or 8,000 mg/kg. Most interestingly, from the second day of treatment, animals that received 8000mg/kg of ACE, displayed a significant lower body weight than the control.

Aspirin, an analgesic antipyretic and anti-inflammatory drug, was used as a positive control in this study. The mechanisms of actions of aspirin that are responsible for all those effects are believed to be involved with both central and peripheral mechanisms.\[[@ref16]\] In this study, ACE, at 800 mg/kg, showed an antipyretic and analgesic effect, which is comparable to aspirin at 150 mg/kg, but without anti-inflammatory properties. A comparable drug, such as paracetamol, also displays analgesic and antipyretic effects without anti-inflammatory action, and it is proposed to act preferentially within the central nervous system through inhibition of a specific form of cyclooxygenase.\[[@ref16]\] It might be possible that ACE, at the dose tested, acts in a similar pattern as paracetamol on the COX3 target, but not as aspirin or other NSAIDs, by centrally producing those effects. However, a higher dose of ACE might be able to show anti-inflammatory activity, since the ethanolic extract of *A. sinensis* displayed analgesic and anti-inflammatory at the dose of 848 but not 424 mg/kg,\[[@ref8]\] and the heartwood of *A. crassna* inhibited LPS-induced tumor necrosis factor-alpha production by attenuating P38 MAPK activation.

The anti-oxidative activity of ACE possibly is one of the important properties, and although the extract was found less active than ascorbic acid, this activity may be linked with the phenolic part of the mixture of ACE. Oxidative mechanisms are proposed to be responsible for many neuronal disorders\[[@ref2][@ref17]\] and plant compounds are suggested to be neuroprotectants due to their anti-oxidative properties.\[[@ref17]\] Many substances have been identified from fresh stem of *A. sinensis* such as aquilarin A, balanophonin and (+)-lariciresinol\[[@ref18]\] and this part of the mixture might also be present in ACE and act as an antioxidant.

In this study, animals treated with the extract of *A. crassna*, 8,000 mg/kg, had a significant reduction of body weight. Recently, the laxative effect of *A. sinensis* has been reported and explained via acetylcholine receptor mediated acceleration of the gastrointestinal transit.\[[@ref19][@ref20]\] Laxative effect of *A. sinensis* was even observed in rats with low-fiber diet-induced constipation without causing any diarrhea and the authors suggested that *A. sinensis* may be useful as a therapeutic laxative agent in humans. In addition, α-glucosidase inhibitors were reported to be present in *A. sinensis* leaves which might interfere the absorption of carbohydrate food.\[[@ref20][@ref11]\] It might be the case that *A. crassna* leaves extract exerts its effect on body weight through both mechanisms and these need to be further elucidated.

In conclusion, this study suggests the possibility of using *A. crassna* leaves and a formulation thereof as an analgesic and antipyretic food supplement. Further, a medicinal application of the antioxidant and the possible α-glucosidase inhibiting property of the extract might have some roles in the treatment and prevention of metabolic disorders.
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